Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection

Exportin 4 (XPO4) is a novel identified candidate tumour‐suppressor gene involved in the pathogenesis of hepatocellular carcinoma (HCC). This study was aimed to determine the clinical features of XPO4 mRNA expression and promoter methylation status in peripheral blood mononuclear cells (PBMCs) of patients with chronic hepatitis B virus (HBV) infection. PBMCs were isolated from 44 HCC, 38 liver cirrhosis (LC), 34 chronic hepatitis B (CHB) patients and 17 healthy controls (HCs). The mRNA level and promoter methylation status of XPO4 were determined by quantitative real‐time RT‐PCR and methylation‐specific PCR, respectively. XPO4 mRNA level of HCC patients was significantly lower compared with LC and CHB patients as well as HCs (all P < 0.01, respectively), and significant differences of the XPO4 mRNA level were found in LC and CHB group than in HCs (LC vs HCs, P < 0.01; CHB vs HCs, P < 0.05). Methylation rate of XPO4 promoter was significantly increased in patients with HCC than in patients with CHB and HCs (both P < 0.05). DNA methylation pattern was responsible for the suppression of XPO4 transcription in the progression of HBV infection (P = 0.000). Furthermore, AFP level was significantly higher in HCC patients with XPO4 methylation than in those without methylation ((8702 ± 15635) μm vs (1052 ± 5370) μm, P < 0.05). In conclusion, transcription of XPO4 gene was gradually decreased and methylation rate of XPO4 promoter was increased with the progression of HBV infection. Methylation status of XPO4 in PBMCs tended to be a noninvasive biomarker to predict HCC and the progression of HBV infection.

[1]  R. Thimme,et al.  Natural history of chronic hepatitis B virus infection , 2014, Medical Microbiology and Immunology.

[2]  Zhijun Huang,et al.  miR‐370 is stage‐specifically expressed during mouse embryonic development and regulates Dnmt3a , 2013, FEBS letters.

[3]  Z. Zeng,et al.  Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays , 2012, Journal of Molecular Histology.

[4]  G. Kang.  CpG Island Hypermethylation in Gastric Carcinoma and Its Premalignant Lesions , 2012, Korean journal of pathology.

[5]  M. Wielscher,et al.  DNA methylation testing and marker validation using PCR: diagnostic applications , 2012, Expert review of molecular diagnostics.

[6]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[7]  Minshan Chen,et al.  Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma , 2011, Journal of gastroenterology and hepatology.

[8]  F. Zoulim,et al.  Hepatitis B virus: from diagnosis to treatment. , 2010, Pathologie-biologie.

[9]  B. McMahon,et al.  Chronic hepatitis B: Update 2009 , 2009, Hepatology.

[10]  Jeroen A. A. Demmers,et al.  Exportin 4 mediates a novel nuclear import pathway for Sox family transcription factors , 2009, The Journal of cell biology.

[11]  K. Koike,et al.  Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)‐β signaling from tumor suppression to oncogenesis in early chronic hepatitis B , 2009, Hepatology.

[12]  A. Krasnitz,et al.  An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer , 2008, Cell.

[13]  D. Steinemann,et al.  Losses of Chromosome Arms 4q, 8p, 13q and Gain of 8q Are Correlated with Increasing Chromosomal Instability in Hepatocellular Carcinoma , 2008, Pathobiology.

[14]  Katsunori Yoshida,et al.  Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma , 2007, Hepatology.

[15]  H. Matsui,et al.  Reversible Smad-dependent signaling between tumor suppression and oncogenesis. , 2007, Cancer research.

[16]  X. Guan,et al.  Characterization of rearrangements involving 4q, 13q and 16q in hepatocellular carcinoma cell lines using region-specific multiplex-FISH probes. , 2007, Cancer letters.

[17]  Boping Zhou,et al.  Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. , 2006, International immunology.

[18]  S. Ishikawa,et al.  Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays , 2006, Oncogene.

[19]  C. Heldin,et al.  The Mechanism of Nuclear Export of Smad3 Involves Exportin 4 and Ran , 2006, Molecular and Cellular Biology.

[20]  F. Chisari,et al.  Immunobiology and pathogenesis of viral hepatitis. , 2006, Annual review of pathology.

[21]  D. Brutlag,et al.  A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Yalnız,et al.  Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. , 2005, World journal of gastroenterology.

[23]  E. Kuipers,et al.  Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection , 2005, Hepatology.

[24]  J. Issa,et al.  A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.

[25]  Trygve O. Tollefsbol,et al.  Aging, cancer and nutrition: the DNA methylation connection , 2003, Mechanisms of Ageing and Development.

[26]  Katsunori Yoshida,et al.  p38 MAPK mediates fibrogenic signal through smad3 phosphorylation in rat myofibroblasts , 2003, Hepatology.

[27]  R. Jordan,et al.  Molecular viral oncology of hepatocellular carcinoma , 2003, Oncogene.

[28]  Jingde Zhu,et al.  Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis , 2002, BMC Cancer.

[29]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[30]  H. Kumada,et al.  [Chronic hepatitis B]. , 2001, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[31]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[32]  M. Sporn,et al.  The Transforming Growth Factor‐Betas: Past, Present, and Future , 1990, Annals of the New York Academy of Sciences.

[33]  Xiao-Dan WuKai.  Transforming growth factor-b genetic polymorphisms on development of liver cirrhosis in a meta-analysis , 2013 .

[34]  K. Zeng,et al.  Transforming growth factor-β genetic polymorphisms on development of liver cirrhosis in a meta-analysis , 2012, Molecular Biology Reports.

[35]  Norman Gitlin,et al.  Chronic hepatitis B : an update , 2010 .

[36]  M. Zoli,et al.  Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? , 2006, The American journal of gastroenterology.

[37]  吉田 勝紀.  Transforming growth factor-β and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury , 2005 .

[38]  T. Tollefsbol,et al.  Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts , 2002, Journal of cellular biochemistry.

[39]  Mark A. Kane.  Weltweite Epidemiologie der Hepatitis B , 1998 .

[40]  M. Kane.  [World-wide epidemiology of hepatitis B]. , 1998, Sozial- und Praventivmedizin.

[41]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.